Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure

European Journal of Heart Failure

Volumn 8, Issue 1, 2006, Pages 58-62

  George, Jacob ^a   Wexler, Dov ^a   Roth, Arie ^a   Barak, Tomer ^a   Sheps, David ^a   Keren, Gad ^a  

^a NONE

Author keywords

Antibodies; Heart failure; Oxidative stress; Oxidized LDL; Pro BNP

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CLINICAL FEATURE; CLINICAL PRACTICE; CORRELATION ANALYSIS; FEMALE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MALE; NATRIURETIC PEPTIDE, BRAIN; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 29444435767     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.04.015     Document Type: Article

References (25)

1. C. Lenfant Report of the task force on research in heart failure Circulation 90 1994 1118 1123
2. K.K. Griendling, and G.A. FitzGerald Oxidative stress and cardiovascular injury: Part II. Animal and human studies Circulation 108 2003 2034 2040
3. P.A. MacCarthy, and A.M. Shah Oxidative stress and heart failure Coron Artery Dis 14 2003 109 113
4. C.E. Myers, W.P. McGuire, R.H. Liss, I. Ifrim, K. Grotzinger, and R.C. Young Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumour response Science 197 1977 165 167
5. P.K. Singal, N. Kapur, K.S. Dhillon, R.E. Beamish, and A.K. Dhalla Role of free radicals in catecholamine-induced cardiomyopathy Can J Physiol Pharmacol 60 1982 1390 1397
6. A.K. Dhalla, M.F. Hill, and P.K. Singal Role of oxidative stress in transition of hypertrophy to heart failure J Am Coll Cardiol 28 1996 506 514
7. N. Siveski-Iliskovic, M. Hill, D.A. Chow, and P.K. Singal Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect Circulation 91 1995 10 15
8. P.A. Sobotka, M.D. Brottman, Z. Weitz, A.J. Birnbaum, J.L. Skosey, and E.J. Zarling Elevated breath pentane in heart failure reduced by free radical scavenger Free Radic Biol Med 14 1993 643 647
9. J. McMurray, M. Chopra, I. Abdullah, W.E. Smith, and H.J. Dargie Evidence of oxidative stress in chronic heart failure in humans Eur Heart J 14 1993 1493 1498
10. 2[alpha] in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure Circulation 97 1998 1536 1539
11. G.R. Ellis, R.A. Anderson, D. Lang, D.J. Blackman, R.H.K. Morris, and J. Morris-Thurgood Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short and long-term vitamin C therapy J Am Coll Cardiol 36 2000 1474 1482
12. A. Boullier, D.A. Bird, M.K. Chang, E.A. Dennis, P. Friedman, and K. Gillotre-Taylor Scavenger receptors, oxidized LDL, and atherosclerosis Ann N Y Acad Sci 947 2001 214 222
13. P. Holvoet, J. Vanhaecke, S. Janssens, F. Van de Werf, and D. Collen Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494
14. P. Holvoet, A. Mertens, P. Verhamme, K. Bogaerts, G. Beyens, and R. Verhaeghe Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 2001 844 848
15. T. Takashi, T. Takayoshi, and W. Atsuyuki Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure J Am Coll Cardiol 39 2002 957 962
16. A. Steirova, J. Racek, and F. Stozicky Antibodies against oxidized LDL- theory and clinical use Physiol Res 50 2001 131 141
17. J.T. Salonen, S. Yla-Herttuala, and R. Yamamoto Autoantibodies against oxidized LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
18. T. Lehtimaki, S. Lehtinen, and T. Solakivi Autoantibodies against low density lipoprotein in patients with angiographicly verified coronary artery disease Arterioscler Thromb Vasc Biol 19 1999 23-2
19. M. Puurunen, M. Manttari, and V. Manninen Antibody against oxidized low density lipoprotein predicting myocardial infarction Arch Intern Med 154 1994 2605 2609
20. J. George, D. Harats, E. Bakshi, Y. Adler, Y. Levy, and B. Gilburd Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty Immunol Lett 68 1999 263 266
21. S.P. Wright, R.N. Doughty, A. Pearl, G.D. Gamble, G.A. Whalley, and H.J. Walsh Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial J Am Coll Cardiol 42 2003 1793 1800
22. I.S. Anand, L.D. Fisher, Y.T. Chiang, R. Latini, S. Masson, and A.P. Maggioni Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1278 1283
23. E. Maggi, R. Bellazzi, and A. Gazo Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis Kidney Int 46 1994 869 876
24. F. Bergesio, G. Monzani, and R. Ciuti Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids Nephron 87 2001 127 133
25. J.A. Doust, P.P. Glasziou, E. Pietrzak, and A.J. Dobson A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure Arch Intern Med 164 2004 1978 1984